bf/NASDAQ:BEAM_icon.jpeg

NASDAQ:BEAM

Beam Therapeutics Inc.

  • Stock

USD

Last Close

32.17

26/07 20:00

Market Cap

1.97B

Beta: 1.63

Volume Today

1.07M

Avg: 953.62K

PE Ratio

−6.78

PFCF: −5.38

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-8.00M
-
-116.74M
1,358.86%
-78.33M
32.90%
-194.59M
148.44%
-370.64M
90.47%
-289.09M
22.00%
-132.53M
54.16%
depreciation and amortization
11K
-
650K
5,809.09%
3.50M
438.92%
4.74M
35.17%
7.45M
57.36%
14.15M
89.87%
20.01M
41.46%
deferred income tax
500K
-
11.75M
2,249.80%
4.48M
61.87%
63.52M
1,317.81%
-16.77M
126.39%
-146.40M
-
stock based compensation
198K
-
7.00M
3,436.36%
7.03M
0.37%
15.38M
118.84%
43.57M
183.29%
84.32M
93.53%
98.65M
16.99%
change in working capital
740K
-
10.07M
1,261.49%
-10.71M
206.25%
5.35M
149.95%
111.25M
1,980.68%
251.63M
126.17%
-116.45M
146.28%
accounts receivables
-300M
-
300M
200%
-146K
100.05%
inventory
300M
-
-300M
200%
accounts payables
726K
-
2.44M
235.54%
4.09M
67.98%
60K
98.53%
818K
1,263.33%
2.37M
190.10%
-7.58M
419.34%
other working capital
14K
-
7.64M
54,464.29%
-14.80M
293.70%
5.29M
135.73%
110.44M
1,988.82%
249.25M
125.70%
-108.73M
143.62%
other non cash items
3.85M
-
66.96M
1,641.13%
2.02M
96.99%
9.87M
389.39%
158.86M
1,509.36%
-38.48M
124.22%
127.52M
431.39%
net cash provided by operating activities
-2.71M
-
-20.30M
649.83%
-72.00M
254.73%
-95.74M
32.97%
-66.27M
30.78%
22.53M
133.99%
-149.19M
762.29%
investments in property plant and equipment
-346K
-
-13.12M
3,693.06%
-12.52M
4.62%
-16.36M
30.67%
-46.81M
186.18%
-48.95M
4.57%
-33.73M
31.09%
acquisitions net
54.14M
-
83.77M
54.72%
620K
99.26%
412.38M
66,413.71%
purchases of investments
-300K
-
-130.21M
43,303.33%
-282.36M
116.85%
-777.22M
175.26%
-1.62B
108.05%
-984.34M
39.13%
sales maturities of investments
76.07M
-
198.60M
161.07%
529.27M
166.51%
1.20B
127.60%
1.09B
9.52%
other investing activites
-54.14M
-
-83.77M
54.72%
-412.38M
-
net cash used for investing activites
-346K
-
-13.42M
3,779.77%
-66.66M
396.57%
-100.12M
50.20%
-294.14M
193.78%
-461.34M
56.84%
71.84M
115.57%
debt repayment
-464K
-
-1.57M
238.15%
-2.12M
34.99%
-2.29M
7.98%
-2.25M
1.53%
common stock issued
37.90M
-
319.53M
743.06%
757.45M
137.05%
108.26M
85.71%
278.70M
157.44%
common stock repurchased
-25.19M
-
dividends paid
-12.71M
-
other financing activites
4.98M
-
179.73M
3,506.08%
41.74M
76.77%
4.36M
89.55%
810K
81.43%
5.62M
593.70%
net cash used provided by financing activities
4.98M
-
179.73M
3,506.08%
41.28M
77.03%
322.32M
680.84%
756.14M
134.59%
111.59M
85.24%
276.45M
147.74%
effect of forex changes on cash
-197.69M
-
net change in cash
1.93M
-
146.00M
7,461.11%
-97.38M
166.70%
126.46M
229.86%
395.73M
212.93%
-327.22M
182.69%
203.13M
162.08%
cash at beginning of period
1.93M
-
147.94M
7,561.11%
50.55M
65.83%
177.01M
250.15%
572.74M
223.56%
232.77M
59.36%
cash at end of period
1.93M
-
147.94M
7,561.11%
50.55M
65.83%
177.01M
250.15%
572.74M
223.56%
245.52M
57.13%
435.89M
77.54%
operating cash flow
-2.71M
-
-20.30M
649.83%
-72.00M
254.73%
-95.74M
32.97%
-66.27M
30.78%
22.53M
133.99%
-149.19M
762.29%
capital expenditure
-346K
-
-13.12M
3,693.06%
-12.52M
4.62%
-16.36M
30.67%
-46.81M
186.18%
-48.95M
4.57%
-33.73M
31.09%
free cash flow
-3.05M
-
-33.42M
994.73%
-84.52M
152.89%
-112.10M
32.63%
-113.08M
0.88%
-26.42M
76.63%
-182.93M
592.28%

All numbers in USD (except ratios and percentages)